Latest in News & Research
Disease Activity With Remibrutinib in Chronic Spontaneous Urticaria
Botulinum Toxin Safe, Effective for Refractory Digital Ischemia
High rates of complete response seen for ischemia, ulcers, gangrene; adverse events occurred infrequently
Long-Term Durable Responses to Cemiplimab Seen in Advanced CSCC
Of four patients receiving retreatment with cemiplimab, three remained progression-free at data cutoff
Rocatinlimab Yields Significant Improvements in Atopic Dermatitis
Significant improvements seen in coprimary end points of EASI-75 response and vIGA-AD score of 0 or 1 versus placebo
RSNA: Ultrasound Findings Can ID Cosmetic Filler-Linked Vascular Adverse Events
With ultrasound findings, the exact place where the occlusion occurs can be targeted
CatBoost Model Has Best Performance for Predicting Survival in Melanoma
Model achieved area under the curve values of 0.7577, 0.7595, and 0.7557 for one-, three-, and five-year survival predictions
Dermatoscopes Compared for Dermoscopy Performance, Teledermatology Use
Ambient light and polarized dermatoscopes both enable dermoscopy performance and receipt of teledermatology recommendations
FDA Approves Updated Label for Unloxcyt
Approval is for adults with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or curative radiation
Slight Increase in Global Burden of Psoriasis Seen Through 2021
Age-standardized incidence rate projected to continue increasing through 2050 in males and females based on data through 2021
Melanoma Incidence Has Decreased Among Young Men in the United States
Decline in melanoma incidence seen among men, but not women younger than 40 years; no difference seen between older men and women
Chronic Pruritus Prevalent Among Older Adults
Atopic dermatitis and psychological symptoms were associated with greatest impairment in pruritus-specific QoL
Introducing Amy Jones and PANP360: A New Era for PAs and NPs in Dermatology
PANP360 brings dermatology PAs and NPs a place to learn, connect, and grow—clinically and as whole people.
Prevalence of Primary Epithelioid Sarcoma Is 0.49 per 100,000 in the U.S.
Prevalence was highest among Whites, lowest among American Indians; highest prevalence seen for those aged 35 to 39 years
Study Compares Treatment Modalities for Management of Keloids
Intralesional triamcinolone acetonide had greatest efficacy, with relatively favorable side effect profile
Melanoma Clusters Identified in Pennsylvania Counties Near Farmland
Increase in cultivated land and herbicide-treated acreage independently linked to increase in melanoma incidence
Eczema Symptoms Do Not Differ With Daily, Weekly Bathing
No significant difference seen in mean POEM score for weekly versus daily bathing over four weeks
Pregnancy-Associated Melanomas Exhibit Distinct Clinicopathologic Features
Eighty percent of PAMs are superficial spreading; 57.1 percent developed on preexisting nevus
Antibiotic Exposure Linked to Biologic Discontinuation in Psoriasis
Stronger effect seen for multiple dispensations, suggesting dose-response relationship
Icotrokinra Beneficial for Adults, Teens With Plaque Psoriasis
Icotronkinra results in significantly higher incidence of complete skin clearance at week 16 than placebo
ACAAI: Eczema Onset, Severity Can Affect Child's Ability to Outgrow Food Allergy
Onset of eczema between 4 and 6 months, greater severity, and longer duration linked to lower likelihood of outgrowing allergies
ACAAI: COVID-19 Vaccination Reduces Risk for Multiple Infections in Children With Atopic Dermatitis
Reduced risks seen for multiple infections and for allergic complications, including asthma, allergic rhinitis, contact dermatitis
ACAAI: Breast Implant Complications, Revision Surgery More Likely in Patients With Eczema
Patients with atopic diseases also have increased risks for complications, revision surgery after bone grafting
FDA Warns 18 Websites for Selling Fake Botox Linked to Injuries
Botox should only be given by licensed medical professionals using FDA-approved products, the agency warned
24 of 1167